Notably, two samples that were equivocal or negative by FISH (13% and 18% of rearranged tumor nuclei) were found to be positive by NGS, with KIF5B as the fusion partner, pointing toward the importance of checking both borderline positive and borderline negative samples. The gene discussed is KIF5B; the disease is neoplasm.